Terramed Alliance News Healthy Diet Can’t Hurt, May Help Breast Cancer Patients

Breast cancer is the second leading cause of cancer death in women in the United States, with approximately 180,000 cases diagnosed each year. Researchers continue to evaluate environmental factors, such as diet, that influence the development of breast cancer. Numerous studies have provided a wealth of often-contradictory information about the detrimental and protective factors of different foods. High fruit and vegetable consumption has been associated with a reduced risk for developing at least 10 different cancers. Studies evaluating the influence of diet on breast cancer prognosis have produced inconsistent results.

Researchers from California and Utah assessed a cohort of 1,901 women from the Life After Cancer Epidemiology (LACE) Study who were diagnosed with early-stage breast cancer between 1997 and 2000. Upon entering the study, the women completed a food frequency questionnaire (FFQ). The researchers used the data from the FFQs to identify two dietary patterns among the women: a prudent diet included high intakes of fruits, vegetables, whole grains, and poultry, whereas a Western diet included high intakes of red and processed meats and refined grains. The researchers then evaluated the rates of recurrence, overall death, death from breast cancer, and death from causes other than breast cancer. As of May 2008, there were 268 breast cancer recurrences and 226 deaths, 128 of which were attributed to breast cancer.

» Read more: Terramed Alliance News Healthy Diet Can’t Hurt, May Help Breast Cancer Patients

Related posts

Pink rink makes fans think, raises money to fight cancer

Pink rink makes fans think, raises money to fight cancer
NORFOLK Just about everything at the Norfolk Admirals hockey game was turned pink Saturday night. Even the ice. The “Pink in the Rink” game was a fundraiser for the Tidewater affiliate of Susan G. Komen for the Cure, which fights breast cancer.

Read more on The Virginian-Pilot

Related posts

BioSante plans new prostate cancer drug testing

BioSante plans new prostate cancer drug testing
BioSante Pharmaceuticals Inc. said Monday it hopes to restart testing of an experimental prostate cancer drug almost two years after the research was stopped.

Read more on AP via Yahoo! Finance

Related posts